I am an investor

Read more

I want to know more about
Cantargia's research

Read more

I want to know more about
Cantargia as a company

Read more

Presentation of Cantargia’s report for the third quarter of 2021

November 11th at 3.00 PM CET

To Audiocast

Cantargia in a panel discussion on how to build a successful biotech company

Panel discussion (in Swedish)

”Looking back at the past year, Cantargia now stands on even firmer ground than we did a year ago, despite everything. We have made progress both on our main project, CAN04, and on our second project, CAN10.”


Göran Forsberg
CEO Cantargia